SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8 – K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: August 14, 2009
(Date of earliest event reported)
MEDICAL ACTION INDUSTRIES INC.
(Exact name of registrant as specified in its charter)
(Former name or former address, if changed since last report)
| | | | |
| Delaware | | 0-13251 | | 11-2421849 |
(State or other jurisdiction of incorporation | | (Commission File Number) | | (IRS Employer Identification Number) |
| | |
500 Expressway Drive South, Brentwood, New York | | 11717 |
| (Address of principal executive offices) | | (Zip Code) |
(631) 231-4600
Registrant’s telephone number including area code
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Table of Contents
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On August 14, 2009, Bernard Wengrover retired as a member of Registrant’s Board of Directors. Mr. Wengrover, 84 years of age, has been a member of Registrant’s Board of Directors since 1990 and at the time of his retirement was serving in Class I with a term to expire in 2011. Mr. Wengrover was the Registrant’s independent auditor from 1997 until March 31, 1989. As a result of Mr. Wengrover’s retirement, the size of the Registrant’s Board of Directors will be reduced to six Directors. Registrant has no disagreement with Mr. Wengrover on any matters relating to its operations, policies or practices.
| Item 9.01 | Financial Statements and Exhibits. |
| | (10) | Letter of Mr. Bernard Wengrover. |
The information in this Form 8-K is being furnished under Item 12 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of such Section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | |
| MEDICAL ACTION INDUSTRIES INC. |
| |
| By: | | /s/ Richard G. Satin |
| | Richard G. Satin, |
| | Vice President - General Counsel |
Dated: August 14, 2009
